Neurocrine Biosciences Inc (NBIX.OQ)
Get access to over 18 million research reports from over 1,700 sources.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
- private equity
- third-party document and information retrieval
- and much, much more…
|68||2011||Independent Chairman of the Board|
|58||2017||Chief Executive Officer, Director|
|38||2017||Chief Financial Officer|
|51||2015||Chief Commercial Officer|
|59||2012||Chief Development Officer|
- BRIEF-Neurocrine Biosciences Presents Long-Term Data Analyses From Open-Label Kinect 4 Phase III Study
- BRIEF-Neurocrine Biosciences appoints Matt Abernethy as CFO
- BRIEF-Neurocrine Biosciences reports Q3 loss per share $0.13
- BRIEF-Abbvie receives U.S. FDA priority review for investigational Oral Treatment Elagolix
- BRIEF-Neurocrine initiates Phase IIb clinical study of Ingrezza